Press release
Increasing Incidence Of Cardiovascular Diseases Drives Growth In The Beta Blockers Market: A Key Factor Shaping the Future of the Beta Blockers Market in 2025
Beta Blockers Market
The beta blockers market's growth is expected to be fuelled by the increasing cases of cardiovascular diseases. These diseases, which are a collective term for disorders affecting the heart and blood vessels, are steadily on the rise due to unhealthy eating habits, sedentary lifestyles, tobacco consumption, and obesity. Beta blockers can mitigate the occurrence of cardiovascular cases due to their favourable impact on the heart and blood vessels. Consequently, the rising prevalence of cardiovascular diseases is catalysing the expansion of the beta blockers market. The British Heart Foundation, a cardiovascular research charity, provided data in September 2024 revealing that an approximate 7.6 million individuals in the UK are grappling with heart and circulatory diseases. Out of these, around 4 million are males and 3.6 million are females. These diseases account for approximately 27% of all deaths in the UK, representing over 170,000 deaths per year, or about 480 deaths daily, which equates to one death every three minutes. Therefore, escalating instances of cardiovascular diseases are expected to further drive the beta blockers market expansion.
Get Your Beta Blockers Market Report Here:
https://www.thebusinessresearchcompany.com/report/beta-blockers-global-market-report
What is the projected compound annual growth rate (CAGR) of the beta blockers market from 2025 to 2034, and what factors influence it?
The market size for beta blockers has shown robust growth in the past few years. The size of the market is forecasted to expand from $9.67 billion in 2024 to $10.28 billion in 2025, marking a compound annual growth rate (CAGR) of 6.3%. The past growth of the market is credited to its use in managing hypertension, treating cardiovascular diseases, care after a myocardial infarction, preventing migraines, as well as management of anxiety and tremors.
The market size for beta blockers is anticipated to experience robust growth in the ensuing years. It is projected to escalate to "$13.11 billion by 2029, with a compound annual growth rate (CAGR) of 6.3%. The growth during the forecast period is owing to the increasing occurrence of cardiovascular diseases, the extension of applications in heart failure treatments, combined treatment methods, focus on hypertension guidelines, and exploration of new potential indications. Significant trends in this forecast period encompass their use in anxiety and high-stress situations, possible neuroprotective impacts, tailor-made treatment strategies, the influence of generic versions, and amalgamation with digital health solutions.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10684&type=smp
How are the latest trends influencing the growth of the beta blockers market?
Leading participants in the beta-blockers market are directing their efforts towards pioneering products such as cardioselective beta-blockers and ultra-short-acting beta-blockers with the aim to enhance results in cardiovascular health. Cardioselective beta-blockers primarily target ß1 receptors located in the heart, reducing respiratory side effects and bolstering efficacy through advanced formulations. Ultra-short-acting beta-blockers like Landiolol offer quick initiation and termination of action, making them perfect for emergency care settings and critical patients who require immediate heart rate regulation. For example, in January 2022, Eagle Pharmaceuticals, Inc., a pharmaceutical corporation based in the US, disclosed its new drug application (NDA) filing for Landiolol, a beta-1 adrenergic blocker, purposed for the brief reduction of ventricular rates in patients suffering from supraventricular tachycardia, including conditions like atrial fibrillation and atrial flutter. The main objective of this move is to bring Landiolol into the U.S. market, broadening the footprint of Eagle Pharmaceuticals in the area of acute care and ultimately enhancing treatment alternatives for patients with tachycardia.
What are the major segments of the beta blockers market and their role in driving growth?
The beta blockers market covered in this report is segmented -
1) By Type: Non-selective Agents, Selective Agents
2) By Indication: Angina Pectoris, Heart Failure, High Blood Pressure, Other Indications
3) By Drugs: Betaxolol, Acebutolol, Esmolol, Other Drugs
4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
5) By Application: Cardiac Diseases, Hypertension, Glaucoma, Other Applications
Subsegments:
1) By Non-Selective Agents: Propranolol, Nadolol, Timolol
2) By Selective Agents: Atenolol, Metoprolol, Bisoprolol, Nebivolol
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10684
Which regions are key players in the growth of the beta blockers market?
North America was the largest region in the beta blockers market in 2024.Asia-Pacific is expected to be the fastest-growing region in the global beta-blockers market report during the forecast period. The regions covered in the beta blockers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Who are the key firms paving the way for growth in the beta blockers market?
Major companies operating in the beta blockers market include Pfizer Inc., Novartis AG, Merck & Co. Inc., AstraZeneca plc, Johnson and Johnson, Eli Lilly and Company, Sanofi SA, Bristol-Myers Squibb Company, Bayer AG, GlaxoSmithKline plc, Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Amneal Pharmaceuticals LLC, Abbott Laboratories, Eagle Pharmaceuticals Inc., Neon Healthcare Ltd., Midas Pharma GmbH, Global Calcium PVT. LTD., AbbVie Inc., Mylan N.V., Boehringer Ingelheim International GmbH, Aspen Pharmacare Holdings Limited, Lupin Limited, Torrent Pharmaceuticals Ltd., Dr. Reddy's Laboratories Ltd., Cipla Ltd., Sandoz International GmbH, Wockhardt Ltd., Endo Pharmaceuticals Inc., Apotex Inc.
Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=10684&type=smp
What Is Covered In The Beta Blockers Global Market Report?
• Market Size Forecast: Examine the beta blockers market size across key regions, countries, product categories, and applications.
• Segmentation Insights: Identify and classify subsegments within the beta blockers market for a structured understanding.
• Key Players Overview: Analyze major players in the beta blockers market, including their market value, share, and competitive positioning.
• Growth Trends Exploration: Assess individual growth patterns and future opportunities in the beta blockers market.
• Segment Contributions: Evaluate how different segments drive overall growth in the beta blockers market.
• Growth Factors: Highlight key drivers and opportunities influencing the expansion of the beta blockers market.
• Industry Challenges: Identify potential risks and obstacles affecting the beta blockers market.
• Competitive Landscape: Review strategic developments in the beta blockers market, including expansions, agreements, and new product launches.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Increasing Incidence Of Cardiovascular Diseases Drives Growth In The Beta Blockers Market: A Key Factor Shaping the Future of the Beta Blockers Market in 2025 here
News-ID: 3892602 • Views: …
More Releases from The Business Research Company
Company Registration Service Market Landscape 2025: Forecast Data and Growth Str …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Company Registration Service Market Through 2025?
The market size for company registration services has seen robust growth in the recent past. The market is projected to expand from $10.67 billion in 2024 to $11.55 billion in 2025, exhibiting a compound annual growth…
Comprehensive 2025 Commercial Toilet Partition Market Overview: Trends, Forecast …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Commercial Toilet Partition Market Through 2025?
In recent years, the market size for commercial toilet partitions has significantly expanded. The forecast predicts a rise from $1.82 billion in 2024 to $1.95 billion in 2025, with a compound annual growth rate (CAGR) of…
Key Trends Influencing the Growth of the Commercial Insurance For Small And Medi …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Commercial Insurance For Small And Medium-Sized Enterprises (SMEs) Market Through 2025?
The market size of commercial insurance for small and medium-sized enterprises (SMEs) has seen substantial growth over the recent years. A rise from $111.83 billion in 2024 to $119.76 billion in…
Growing Focus On Reducing Greenhouse Gas Emissions Driving The Market Growth Due …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Combustion Emissions Analyzer Market Through 2025?
In the past few years, the market size for combustion emissions analyzer has seen robust growth. It is projected to increase from $1.02 billion in 2024 to $1.09 billion in 2025, with a compound annual growth…
More Releases for Pharma
Miglitol Market Size, Share and Forecast By Key Players-Weiao Pharma, Zhejiang M …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Miglitol market is anticipated to grow at a compound annual growth rate (CAGR) of 11.49% between 2024 and 2031. The market is expected to grow to USD 22.32 Billion by 2024. The valuation is expected to reach USD 47.79 Billion by 2031.
The Miglitol market is experiencing significant growth due to the rising prevalence of diabetes and the increasing awareness of the…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The Dacarbazine market is projected to witness significant growth in the coming years, driven by increasing…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The dacarbazine market is experiencing steady growth, driven by the rising incidence of cancer globally. As…
Epilepsy Pipeline Assessment 2024: Therapies, Clinical Trials, and Market Insigh …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Epilepsy pipeline constitutes 75+ key companies continuously working towards developing 90+ Epilepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
The Epilepsy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the…
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, …
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis.
Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382
The Indomethacin Global Market Research Report provides close monitoring…
Roxatidine Market 2020: Top Companies Analysis To Grow Healthcare Business by 20 …
Business Industry Reports Research has recently announced a report on Global Roxatidine Market based on the Category Industry. The Roxatidine Market report emphasizes various key aspects, which include growth drivers, restraints, opportunities and recent market trends for the forecast period 2020-2024.
Global Roxatidine Market overview:
Business Industry Reports Analyst covers the Major Players data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the…
